Ono Pharmaceutical Co., Ltd. (OPHLY)
4.799
-0.04
(-0.85%)
USD |
OTCM |
Oct 02, 16:00
Ono Pharmaceutical Profit Margin (Quarterly) : 20.80% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 20.80% |
| March 31, 2026 | 0.88% |
| December 31, 2025 | 20.65% |
| September 30, 2025 | 17.25% |
| June 30, 2025 | 13.82% |
| March 31, 2025 | -5.67% |
| December 31, 2024 | 11.09% |
| September 30, 2024 | 13.71% |
| June 30, 2024 | 21.10% |
| March 31, 2024 | 15.46% |
| December 31, 2023 | 27.51% |
| September 30, 2023 | 30.79% |
| June 30, 2023 | 26.51% |
| March 31, 2023 | 15.80% |
| December 31, 2022 | 27.29% |
| September 30, 2022 | 29.93% |
| June 30, 2022 | 27.67% |
| March 31, 2022 | 17.81% |
| December 31, 2021 | 18.83% |
| September 30, 2021 | 25.63% |
| June 30, 2021 | 27.60% |
| March 31, 2021 | 12.06% |
| December 31, 2020 | 31.55% |
| September 30, 2020 | 24.29% |
| June 30, 2020 | 28.74% |
| Date | Value |
|---|---|
| March 31, 2020 | 11.78% |
| December 31, 2019 | 24.99% |
| September 30, 2019 | 22.04% |
| June 30, 2019 | 22.14% |
| March 31, 2019 | 12.94% |
| December 31, 2018 | 18.18% |
| September 30, 2018 | 18.63% |
| June 30, 2018 | 21.41% |
| March 31, 2018 | 14.46% |
| December 31, 2017 | 25.59% |
| September 30, 2017 | 15.67% |
| June 30, 2017 | 19.38% |
| March 31, 2017 | 24.05% |
| December 31, 2016 | 27.27% |
| September 30, 2016 | 16.08% |
| June 30, 2016 | 23.32% |
| March 31, 2016 | 12.35% |
| December 31, 2015 | 17.44% |
| September 30, 2015 | 7.11% |
| June 30, 2015 | 26.56% |
| March 31, 2015 | -9.16% |
| December 31, 2014 | 27.76% |
| September 30, 2014 | 1.34% |
| June 30, 2014 | 9.29% |
| March 31, 2014 | 2.95% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Takeda Pharmaceutical Co., Ltd. | 9.28% |
| Daiichi Sankyo Co., Ltd. | 11.94% |
| Astellas Pharma, Inc. | 22.12% |
| Eisai Co., Ltd. | 8.17% |
| Chugai Pharmaceutical Co., Ltd. | 34.06% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 9.20% |
| Return on Assets | 7.15% |
| Return on Invested Capital | 7.98% |
| Gross Profit Margin (Quarterly) | 75.31% |
| Operating Margin (Quarterly) | 26.84% |
| Return on Net Operating Assets | 11.09% |